Skip to main content
. 2022 Nov 11;13:1053819. doi: 10.3389/fimmu.2022.1053819

Table 3.

Identification of RM drug candidates.

Drug P-value Odds Ratio Combined Score Drug Targets
Irinotecan 4.88E-04 19.68980021 150.1446587 MBNL2;TBC1D12;PUM1;CD2AP
Alsterpaullone 0.011055064 9.478342428 42.69866877 MBNL2;TBC1D12;PUM1
Camptothecin 0.011584032 9.306841046 41.49108607 MBNL2;TBC1D12;PUM1
Chlorzoxazone 0.007629886 10.93725643 53.32658862 ACTR2;RPN2;PUM1
GW-8510 0.007696558 10.9009324 53.05464254 MBNL2;TBC1D12;PUM1
POTASSIUM 0.022293962 7.162796834 27.24326379 MBNL2;TBC1D12;CD2AP
(-)-Epigallocatechin 0.029804748 6.349786932 22.3073575 MBNL2;TBC1D12;CD2AP
Verteporfin 0.003997787 28.05978648 154.9465424 NCSTN;RPN2
Strophanthidin 0.005850578 22.98362573 118.1637568 ACTR2;PUM1
Uranium 0.002989614 32.64628099 189.7601315 ACTR2;PUM1
Azacitidine 0.016801262 13.08600337 53.47335226 TBC1D12;PUM1
Etifenin 0.017560467 12.77495881 51.63772641 ACTR2;PUM1
Staurosporine 0.019811159 11.96043277 46.90295556 TBC1D12;PUM1
Neostigmine 0.019868958 11.94135802 46.79336577 ACTR2;PUM1
Meclofenoxate 0.023657885 10.84781997 40.61487591 ACTR2;NCSTN
Captopril 0.033293867 8.96440281 30.5003233 ACTR2;PUM1
Tyrphostin 0.010353604 16.98521739 77.62958757 TBC1D12;PUM1